Weili Wang
- Molecular Biology
- Cell Biology top 10%
- Hematology top 5%
- Immunology
- Cancer Research
- Co-authors
- Weiping YuanTao ChengZhuan LiBing LiuJie ZhouYanli NiXiaohuan MuWenyan He
- Topics
- PI3K/AKT/mTOR signaling in cancer (5 papers)Acute Myeloid Leukemia Research (4 papers)Multiple Myeloma Research and Treatments (3 papers)
- Cited by
- HematologyCell BiologyImmunology
- Journals
- NatureBloodNature Immunology
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Weili Wang
22 papers receiving 646 citations
Peers
Comparison fields: 5 of 73
- Molecular Biology 449
- Cell Biology 185
- Hematology 154
- Immunology 144
- Cancer Research 70
Countries citing papers authored by Weili Wang
This map shows the geographic impact of Weili Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weili Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weili Wang more than expected).
Fields of papers citing papers by Weili Wang
This network shows the impact of papers produced by Weili Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weili Wang. The network helps show where Weili Wang may publish in the future.
Co-authorship network of co-authors of Weili Wang
This figure shows the co-authorship network connecting the top 25 collaborators of Weili Wang. A scholar is included among the top collaborators of Weili Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weili Wang. Weili Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 0 | |
| 5 | 5 | |
| 6 | 2 | |
| 7 | 28 | |
| 8 | 1 | |
| 9 | 7 | |
| 10 | 11 | |
| 11 | 61 | |
| 12 | 263 | |
| 13 | 25 | |
| 14 | 26 | |
| 15 | 14 | |
| 16 | 27 | |
| 17 | 21 | |
| 18 | 8 | |
| 19 | 5 | |
| 20 | 25 |
About Weili Wang
Weili Wang is a scholar working on Hematology, Nephrology and Cell Biology, having authored 25 papers that have together received 651 indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (5 papers), Acute Myeloid Leukemia Research (4 papers) and Multiple Myeloma Research and Treatments (3 papers). The work is most often cited by research in Hematology (154 citations), Cell Biology (185 citations) and Immunology (144 citations). Weili Wang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Weiping Yuan, Tao Cheng, Zhuan Li, Bing Liu, Jie Zhou, Yanli Ni, Xiaohuan Mu, Wenyan He, Yu Lan and Fuchou Tang. Their work appears in journals such as Nature, Blood and Nature Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.